ADA and cancer: Also, mutation or deficiency of adenosine deaminase, which is a key enzyme for purine metabolite degradation or salvage into the nucleotide pool, increases susceptibility to infections and autoimmunity, and adenosine deaminase activity has been used as a diagnostic marker for cancers (53, 54).